| 1 |
1- Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture induced Alzheimer’s disease in rats: role of AMPK/mTOR, BDNF, BACE 1, neuroinflammation, and oxidative stress |
2025 |
| 2 |
2- Neuroprotective Effect of Empagliflozin/Rivastigmine in Alzheimer's Disease Rat Model: Optimization of Multifaceted Mechanism of Action |
2025 |
| 3 |
3- Prospective Hepatoprotective Actions of Novel Nano formulations of Sildenafil and Neem Extract in Counteracting Oral Carbon Tetrachloride induced Liver Injury in Rats |
2025 |
| 4 |
A novel nanoparticle glutathione and Lepidium sativum treatment for gentamicin-induced acute renal failure in rats |
2025 |
| 5 |
MDFIC2 is a PIEZO channel modulator that can alleviate mechanical allodynia associated with neuropathic pain |
2025 |
| 6 |
Neuroprotective Effects of Liraglutide and/or Rivastigmine Combination on the Rat Hippocampus |
2025 |
| 7 |
Prospective Hepatoprotective Actions of Novel Nano-formulations of Sildenafil and Neem Extract in Counteracting Oral Carbon Tetrachloride-induced Liver Injury in Rat |
2025 |
| 8 |
Traditional Chinese medicine and natural small molecules for pain treatment via voltage-gated sodium channels: a review |
2025 |
| 9 |
Vitamin D3 Ameliorates BDL-Induced Hepatocardiac Abnormalities. Possible Role of IGF-1 |
2025 |
| 10 |
Chemotherapeutic potential of betanin/capecitabine combination targeting colon cancer: experimental and bioinformatic studies exploring NFκB and cyclin D1 interplay |
2024 |